Extraction-free clinical detection of SARS-CoV-2 virus from saline gargle samples using Hamilton STARlet liquid handler

Author:

Gadkar Vijay J.,Goldfarb David M.,Al-Rawahi Ghada N.,Srigley Jocelyn A.,Smailus Duane E.,Coope Robin J. N.,Pleasance Stephen,Watson Nicole,Chen Tammy,Lam Sunny,Hoang Linda,Tilley Peter A. G.

Abstract

AbstractAs part of the COVID-19 pandemic, clinical laboratories have been faced with massive increases in testing, resulting in sample collection systems, reagent, and staff shortages. We utilized self-collected saline gargle samples to optimize high throughput SARS-CoV-2 multiplex polymerase chain reaction (PCR) testing in order to minimize cost and technologist time. This was achieved through elimination of nucleic acid extraction and automation of sample handling on a widely available robotic liquid handler, Hamilton STARlet. A customized barcode scanning script for reading the sample ID by the Hamilton STARlet’s software system was developed to allow primary tube sampling. Use of pre-frozen SARS-CoV-2 assay reaction mixtures reduced assay setup time. In both validation and live testing, the assay produced no false positive or false negative results. Of the 1060 samples tested during validation, 3.6% (39/1060) of samples required retesting as they were either single gene positive, had internal control failure or liquid aspiration error. Although the overall turnaround time was only slightly faster in the automated workflow (185 min vs 200 min), there was a 76% reduction in hands-on time, potentially reducing staff fatigue and burnout. This described process from sample self-collection to automated direct PCR testing significantly reduces the total burden on healthcare systems in terms of human resources and reagent requirements.

Funder

Peter Wall Institute for Advanced Studies

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference30 articles.

1. World Health Organization. 2020. Diagnostic testing for SARS-CoV-2: interim guidance, 11 September 2020. WHO/2019-nCoV/laboratory/2020.6. World Health Organization, Geneva, Switzerland. https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2.

2. Centers for Disease Control and Prevention (CDC) (2020) 2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes. 2020a. https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-primer-probes.pdf Accessed 09 April 2020.

3. Azzi, L. et al. Saliva is a reliable tool to detect SARS-CoV-2. J. Infect. 81, e45–e50 (2020).

4. Ranoa, D. R. E. et al. Saliva-based molecular testing for SARS-CoV-2 that bypasses RNA extraction. Biorxiv https://doi.org/10.1101/020.06.18.159434 (2020).

5. Vogels, C. B. F. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med. (N. Y.) 2(3), 263-280.e6 (2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3